Data suggests that acuity values obtained with the Patti Pics optotypes are more consistent with those obtained with a gold standard visual acuity test used for older children and adults.
A major study conducted by Memorial University, St. John’s Newfoundland, Canada and McGill
University, Montreal, Quebec, Canada (KJP) comparing Patti Pics and another leading Pediatric Test using the same patient group of older children and adults offers a rare direct comparison between the two as well as providing evaluation against the ETDRS Gold Standard.
Noted Researcher Dr. August Colenbrander discusses the different points of view between a Doctor who treats a condition versus a Patient whose concerns are more associated with activities of daily living. This video presentation provides instruction on how to bridge the gap between measuring how well the eyes function and determining how well a person functions with the objective of learning more about the societal consequences. Rehabilitation provides a link between these two aspects.
American Optometric Association Cautions Consumers about Claims of Online Eye Exams
Washington, D.C. and St. Louis, Mo. (March 6, 2014)—To protect consumers’ eye and vision health, the American Optometric Association is warning the public about the false claims that internet companies can provide an online “eye exam.” These claims are confusing and misleading.
Smartphones become “eye-phones” with low-cost devices developed by Ophthalmologists
Researchers at the Stanford University School of Medicine have developed two inexpensive adapters that enable a smartphone to capture high quality images of the front and back of the eye. The adapters make it easy for anyone with minimal training to take a picture of the eye and share it securely with other health practitioners or store it in the patient’s electronic record.
New Innovation could mean that eye injections are a thing of the past
Drugs used to treat blindness-causing disorders could be successfully administered by eye drops rather than unpleasant and expensive eye injections, according to new research led by UCL scientists that could be a breakthrough for the millions worldwide suffering from age-related macular degeneration (AMD) and other eye disorders.